HMGB1 and B-cell chronic lymphocytic leukemia: For both CLL cell lines, the magnitude of HMGB1 released into the extracellular space was greatest with 24 h 2 μM SpiD3 treatment, exceeding the magnitude of HMGB1 detected from the positive controls (Figure 3A,C).